SARS-CoV-2 vaccine-related neurological complications need large collaborative studies, not single case reports or small descriptive series
Eur J Neurol
.
2021 Oct;28(10):3223.
doi: 10.1111/ene.14905.
Epub 2021 May 22.
Authors
Didier Leys
1
,
Mark Edwards
2
,
Kristl Vonck
3
,
Pille Taba
4
,
Elena Moro
5
,
Andrew Chan
6
,
Claudia Sommer
7
Affiliations
1
Department of Neurology, Inserm U 1172, University of Lille, Lille, France.
2
Institute of Cardiovascular and Cell Sciences, St. George's University, London, UK.
3
Department of Neurology, Ghent University, Ghent, Belgium.
4
Department of Neurology and Neurosurgery, University of Tartu, Tartu, Estonia.
5
Department of Neurology, Service de Neurologie CHU Grenoble Chemin Fortune Ferrini, CHUGA Isere, La Tronche, France.
6
Department of Neurology, Inselspital Universitätsspital Bern, Bern, Switzerland.
7
Department of Neurology, University of Würzburg, Würzburg, Germany.
PMID:
33966314
DOI:
10.1111/ene.14905
No abstract available
Publication types
Case Reports
Editorial
MeSH terms
COVID-19 Vaccines
COVID-19*
Humans
Nervous System Diseases* / etiology
SARS-CoV-2
Substances
COVID-19 Vaccines